EMA
approval
· 2023-03-03
EMA Authorised: Efavirenz Teva (efavirenz) — Teva B.V.
Summary
EFAVIRZEN Teva has been authorised in the EU for HIV infection treatment.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: HIV Infections. MAH: Teva B.V.. Decision date: 27/02/2023